These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34452307)

  • 1. Serological Evidence of Widespread Zika Transmission across the Philippines.
    Biggs JR; Sy AK; Brady OJ; Kucharski AJ; Funk S; Tu YH; Reyes MAJ; Quinones MA; Jones-Warner W; Ashall J; Avelino FL; Sucaldito NL; Tandoc AO; Cutiongco-de la Paz E; Capeding MRZ; Padilla CD; Hibberd ML; Hafalla JCR
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of eight commercial Zika virus IgM and IgG serology assays for diagnostics and research.
    Low SL; Leo YS; Lai YL; Lam S; Tan HH; Wong JCC; Tan LK; Ng LC
    PLoS One; 2021; 16(1):e0244601. PubMed ID: 33497414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Anti-Dengue and Anti-Zika IgG on a Plasmonic Gold Platform with Neutralization Testing.
    Rojas A; Natrajan MS; Weber J; Cardozo F; Cantero C; Ananta JS; Kost J; Tang M; López S; Bernal C; Guillén Y; Mendoza L; Páez M; Pinsky BA; Waggoner JJ
    Am J Trop Med Hyg; 2021 Mar; 104(5):1729-1733. PubMed ID: 33782214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests.
    Tsai WY; Youn HH; Brites C; Tsai JJ; Tyson J; Pedroso C; Drexler JF; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
    Clin Infect Dis; 2017 Nov; 65(11):1829-1836. PubMed ID: 29020159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological evidence of DENV, JEV, and ZIKV among the indigenous people (Orang Asli) of Peninsular Malaysia.
    Khor CS; Mohd-Rahim NF; Hassan H; Tan KK; Zainal N; Teoh BT; Sam SS; Khoo JJ; Lee HY; Lim YA; Abubakar S
    J Med Virol; 2020 Aug; 92(8):956-962. PubMed ID: 31814135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence.
    van Meer MPA; Mögling R; Klaasse J; Chandler FD; Pas SD; van der Eijk AA; Koopmans MPG; Reusken CBEM; GeurtsvanKessel CH
    J Clin Virol; 2017 Jul; 92():25-31. PubMed ID: 28505571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NS1-Specific Antibody Response Facilitates the Identification of Children With Dengue and Zika in Hyperendemic Areas.
    Castro-Trujillo S; Segura K; Bolívar-Marín S; Salgado DM; Bosch I; Vega R; Rojas MC; Narváez CF
    Pediatr Infect Dis J; 2024 Feb; 43(2):178-185. PubMed ID: 37963312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatal analyses of Zika- and dengue virus-specific neutralizing antibodies: A microcephaly case-control study in an area of high dengue endemicity in Brazil.
    Castanha PMS; Souza WV; Braga C; Araújo TVB; Ximenes RAA; Albuquerque MFPM; Montarroyos UR; Miranda-Filho DB; Cordeiro MT; Dhalia R; Marques ETA; Rodrigues LC; Martelli CMT;
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007246. PubMed ID: 30856223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population.
    Montecillo-Aguado MR; Montes-Gómez AE; García-Cordero J; Corzo-Gómez J; Vivanco-Cid H; Mellado-Sánchez G; Muñoz-Medina JE; Gutiérrez-Castañeda B; Santos-Argumedo L; González-Bonilla C; Cedillo-Barrón L
    J Immunol Res; 2019; 2019():7239347. PubMed ID: 31565661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based survey.
    Nguyen CT; Moi ML; Le TQM; Nguyen TTT; Vu TBH; Nguyen HT; Pham TTH; Le THT; Nguyen LMH; Phu Ly MH; Ng CFS; Takemura T; Morita K; Hasebe F
    BMC Infect Dis; 2020 May; 20(1):332. PubMed ID: 32393198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological and molecular epidemiology of the Dengue, Zika and Chikungunya viruses in a risk area in Brazil.
    Mota ML; Dos Santos Souza Marinho R; Duro RLS; Hunter J; de Menezes IRA; de Lima Silva JMF; Pereira GLT; Sabino EC; Grumach A; Diaz RS; do Socorro Lucena M; Komninakis SV
    BMC Infect Dis; 2021 Jul; 21(1):704. PubMed ID: 34303348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.
    Yamanaka A; Matsuda M; Okabayashi T; Pitaksajjakul P; Ramasoota P; Saito K; Fukasawa M; Hanada K; Matsuura T; Muramatsu M; Shioda T; Suzuki R
    mSphere; 2021 Aug; 6(4):e0033921. PubMed ID: 34259560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Assay to Measure Seroprevalence of Zika Virus in the Philippines.
    Adams C; Jadi R; Segovia-Chumbez B; Daag J; Ylade M; Medina FA; Sharp TM; Munoz-Jordan JL; Yoon IK; Deen J; Lopez AL; de Silva AM; Premkumar L
    Emerg Infect Dis; 2021 Dec; 27(12):3073-3081. PubMed ID: 34808091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capacity of a Multiplex IgM Antibody Capture ELISA to Differentiate Zika and Dengue Virus Infections in Areas of Concurrent Endemic Transmission.
    Medina FA; Vila F; Premkumar L; Lorenzi O; Paz-Bailey G; Alvarado LI; Rivera-Amill V; de Silva A; Waterman S; Muñoz-Jordán J
    Am J Trop Med Hyg; 2021 Dec; 106(2):585-592. PubMed ID: 34929668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
    Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
    Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E
    J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
    Premkumar L; Collins M; Graham S; Liou GA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E; De Silva AD; Giuberti C; Dos Reis HL; Singh T; Heimsath H; Weiskopf D; Sette A; Osorio JE; Permar SR; Miley MJ; Lazear HM; Harris E; de Silva AM
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a new rapid fluorescence immunoassay for the diagnosis of dengue and Zika virus infection.
    Zammarchi L; Colao MG; Mantella A; Capobianco T; Mazzarelli G; Ciccone N; Tekle Kiros S; Mantengoli E; Rossolini GM; Bartoloni A
    J Clin Virol; 2019 Mar; 112():34-39. PubMed ID: 30738366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Added value of IgA antibodies against Zika virus non-structural protein 1 in the diagnosis of acute Zika virus infections.
    Warnecke JM; Lattwein E; Saschenbrecker S; Stöcker W; Schlumberger W; Steinhagen K
    J Virol Methods; 2019 May; 267():8-15. PubMed ID: 30779938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zika Virus Antibody Titers Three Years after Confirmed Infection.
    Langerak T; Kasbergen LMR; Chandler F; Brinkman T; Faerber Z; Phalai K; Ulbert S; Rockstroh A; Bruin E; Koopmans MPG; Rockx B; van Gorp ECM; Vreden S
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.